Research Article

Central Aortic Pressure and Arterial Stiffness in Parkinson’s Disease: A Comparative Study

Table 3

Hemodynamic data according to disease severity and duration in PD patients.

H&Y < 3H&Y ≥ 3-value-value
Before LDAfter LDBefore LDAfter LD

SBP (mm·Hg)148.54 ± 24.55139.07 ± 18.95154.90 ± 37.31137.32 ± 19.140.0010.001
DBP (mm·Hg)83.92 ± 13.7077.47 ± 13.9390.97 ± 22.4777.70 ± 13.140.010.01
PP (mm·Hg)64.61 ± 14.6561.83 ± 13.2964.12 ± 19.6459.62 ± 12.370.0010.02
HR (minute)75.35 ± 12.3678.69 ± 12.7478.95 ± 12.9378.92 ± 12.810.03NS
AI (%)−14.63 ± 28.58−22.33 ± 20.71−12.99 ± 29.25−20.83 ± 30.180.010.01
CAP (mm·Hg)149.84 ± 32.73130.18 ± 19.72147.08 ± 30.55128.99 ± 21.920.0010.001

DD ≤ 5DD > 5-value-value
Before LDAfter LDBefore LDAfter LD
SBP (mm·Hg)148.21 ± 21.13136.40 ± 18.16154.46 ± 37.83139.71 ± 19.640.0010.001
DBP (mm·Hg)85.29 ± 12.7977.24 ± 12.1789.06 ± 22.4677.86 ± 14.570.020.001
PP (mm·Hg)62.91 ± 13.5859.43 ± 14.1365.57 ± 19.6961.84 ± 11.680.0010.01
HR (minute)75.37 ± 12.7877.72 ± 12.1378.53 ± 12.5979.68 ± 13.22NSNS
AI (%)−14.12 ± 29.59−20.22 ± 22.16−13.59 ± 28.36−22.73 ± 28.340.020,01
CAP (mm·Hg)147.68 ± 29.14129.41 ± 17.11149.16 ± 33.67129.75 ± 23.440.0010.001

AI : augmentation index; CAP : central aortic pressure; DBP : diastolic blood pressure; DD : disease duration; HR : heart rate; H&Y : Hoehn and Yahr score; LD :  levodopa; NS: nonsignificant; PP: pulse pressure; SBP : systolic blood pressure; p1: H&Y < 3 before and after LD intake; p2: H&Y ≥ 3 before and after LD intake; p3: DD ≤ 5 before and after LD intake; p4: DD > 5 before and after LD intake; NS: nonsignificant. Bold numbers indicate significance.